Francesco Chelli

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
1. Naltrexone (50 mg bid, p.o.) was administered in a double-blind fashion (with placebo control) to chronic schizophrenic patients who maintained their routine neuroleptic and anxiolytic therapy. 2. Both positive and negative symptom patients who received naltrexone improved with regard to symptoms involving deterioration and social withdrawal. No(More)
  • 1